SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-018877
Filing Date
2022-05-09
Accepted
2022-05-09 16:15:56
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-10q_20220331.htm   iXBRL 10-Q 1842564
2 EX-31.1 hrtx-ex311_8.htm EX-31.1 21768
3 EX-31.2 hrtx-ex312_7.htm EX-31.2 21061
4 EX-32.1 hrtx-ex321_6.htm EX-32.1 17904
  Complete submission text file 0001564590-22-018877.txt   6654134

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20220331.xsd EX-101.SCH 38433
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20220331_cal.xml EX-101.CAL 41359
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20220331_def.xml EX-101.DEF 123135
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20220331_lab.xml EX-101.LAB 332028
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20220331_pre.xml EX-101.PRE 241621
53 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-10q_20220331_htm.xml XML 1239559
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 22905150
SIC: 2834 Pharmaceutical Preparations